The role of tTG IgA (tissue transglutaminase IgA) in longevity is not addressed in the provided context. tTG IgA is a well-established serological marker for celiac disease, an autoimmune condition that, if untreated, can lead to chronic intestinal inflammation, nutrient malabsorption, and increased mortality. Early diagnosis and a gluten-free diet can mitigate these risks, indirectly supporting healthy aging. However, there is no direct evidence from the context that tTG IgA levels themselves serve as a longevity biomarker. The evidence is therefore classified as unclear. MyBody-X does not offer a tTG IgA test; the DNA and microbiome tests mentioned have no connection to this marker. For a robust longevity assessment, other validated biomarkers such as inflammatory markers (CRP, IL-6) or telomere length are more appropriate. Consumers should be cautious about overinterpreting non-validated tests.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-5ae07fa3905d2ae05e975d9b